Daiwa Securities Group
KNSA icon

Daiwa Securities Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Daiwa Securities Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-139
Closed -$6K – 1319
2025
Q4 		$6K Hold
139
– – ﹤0.01% 1220
2025
Q3 		$5K Hold
139
– – ﹤0.01% 1206
2025
Q2 		$4K Hold
139
– – ﹤0.01% 1174
2025
Q1 		$3K Hold
139
– – ﹤0.01% 1166
2024
Q4 		$3K Hold
139
– – ﹤0.01% 1197
2024
Q3 		$3K Hold
139
– – ﹤0.01% 1199
2024
Q2 		$3K Hold
139
– – ﹤0.01% 1231
2024
Q1 		$3K Hold
139
– – ﹤0.01% 1240
2023
Q4 		$2K Hold
139
– – ﹤0.01% 1273
2023
Q3 		$2K Hold
139
– – ﹤0.01% 1219
2023
Q2 		$2K Hold
139
– – ﹤0.01% 1236
2023
Q1 		$1K Hold
139
– – ﹤0.01% 1258
2022
Q4 		$2K Buy
139
+79
+132% +$1.15K ﹤0.01% 1228
2022
Q3 		$1K Hold
60
– – ﹤0.01% 1294
2022
Q2 		$1K Hold
60
– – ﹤0.01% 1294
2022
Q1 		$1K Hold
60
– – ﹤0.01% 1313
2021
Q4 		$1K Hold
60
– – ﹤0.01% 1342
2021
Q3 		$1K Hold
60
– – ﹤0.01% 1272
2021
Q2 		$1K Hold
60
– – ﹤0.01% 1198
2021
Q1 		$1K Hold
60
– – ﹤0.01% 1206
2020
Q4 		$1K Buy
+60
New +$1.05K ﹤0.01% 1186
2019
Q4 		– Sell
-117
Closed -$1K – 1225
2019
Q3 		$1K Hold
117
– – ﹤0.01% 1154
2019
Q2 		$2K Hold
117
– – ﹤0.01% 1147
2019
Q1 		$2K Buy
+117
New +$2.26K ﹤0.01% 1132

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Daiwa Securities Group's KNSA Position: Q1 2026 in Review

Daiwa Securities Group sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2026, closing a stake of 139 shares — an estimated $6K sold.

Daiwa Securities Group first reported a position in KNSA in Q1 2019 and held it in 24 quarters. The position peaked at $6K in Q4 2025. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Daiwa Securities Group reported no remaining Kiniksa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 139 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $6K.
  • Daiwa Securities Group first reported a position in Kiniksa Pharmaceuticals in Q1 2019 and held it in 24 quarters.
  • Daiwa Securities Group's Kiniksa Pharmaceuticals position peaked at $6K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.